[Event Report] The First Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) (September 14, 2020)
- Home >
- Information >
- Event >
- [Event Report] The First Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) (September 14, 2020)
Nikkei Inc. and AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) jointly held the First Meeting of Working Group (WG) 3 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC).
The WGs were established under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) in order to discuss the state of the antimicrobial market.
At this First meeting of WG3, participants discussed messaging on AMR, the priority issues that need to be dealt with in order to increase understanding of AMR, and the causal relationship between those issues.
On the basis of the WG discussions, participants agreed to join the third sub-committee on AMR and continue to work hard toward the eventual formulation of a concrete proposal on ways to incentivize antimicrobial R&D in the future and to promote educational support activities related to AMR for healthcare professionals and the general public.
In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Date and time: Thursday, September 14, 2020
Organizer: AMR Alliance Japan (Secretariat: HGPI), Nikkei Inc.
■Discussion
WG3 Members (alphabetical order by last name):
Kyoko Ama (Board Member, Japan Patient Support Research Organization)
Yoshiaki Gu (Chief, Information and Education Division, AMR Clinical Reference Center, National Center for Global Health and Medicine)
Midori Hirai (Auditor, The Pharmaceutical Society of Japan / Director, Japanese Red Cross Hyogo Blood Center)
Hajime Matsumoto (Public and Industry Policy, Health Policy, MSD K. K.)
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)
Moderator:
Yuiko Kondo (AMR Alliance Japan Secretariat / Senior Associate, HGPI)
Secretariat (alphabetical order by last name):
Yui Kohno (AMR Alliance Japan Secretariat / Associate, HGPI)
Matt McEnany (AMR Alliance Japan Secretariat / Senior Manager, HGPI)
Tomohito Shibata (AMR Alliance Japan Secretariat / Senior Associate, HGPI)
Mio Wakasa (Nikkei FT Communicable Diseases Conference, Nikkei Inc.)
■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)
January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)